Literature DB >> 33263246

Decision on Chemotherapy Amidst COVID-19 Pandemic: A Review and a Practical Approach from Iran.

Afshin Rakhsha1, Samira Azghandi1, Farzad Taghizadeh-Hesary2.   

Abstract

To provide a step-by-step approach to chemotherapy (CTx) in the novel coronavirus disease (COVID-19) era. The COVID-19 pandemic is the current global issue resulting in vast health implications. Amid the COVID-19 era, special attention must be paid to at-risk groups, including patients with cancer. To our knowledge, there is a paucity of data on the decision for CTx during the pandemic. We herein provide practical recommendations on the CTx of cancer patients over the pandemic based on our experience in an educational hospital. The decision on CTx should be considered to be individualized based on clinical findings. We hope that our experience provides a practical guide for clinical oncologists to deliver more effective cancer care over the COVID-19 pandemic.
Copyright © 2020 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.

Entities:  

Keywords:  COVID-19; Cancer; Chemotherapy

Year:  2020        PMID: 33263246

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


  6 in total

1.  Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.

Authors:  Junyi Jiang; WeiJun Zhong; WeiHua Huang; Yongchao Gao; Yijing He; Xi Li; Zhaoqian Liu; Honghao Zhou; Yacheng Fu; Rong Liu; Wei Zhang
Journal:  Ther Clin Risk Manag       Date:  2022-05-17       Impact factor: 2.755

Review 2.  Review on the Oncology Practice in the Midst of COVID-19 Crisis: The Challenges and Solutions.

Authors:  Pedram Fadavi; Mohammad Houshyari; Amir Shahram Yousefi Kashi; Alireza Mosavi Jarrahi; Farnaz Roshanmehr; Mohammad Ali Broomand; Saleh Sandoughdaran; Farzad Taghizadeh-Hesary
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

3.  COVID-19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case-controlled study from Iran.

Authors:  Soodabeh Shahidsales; Seyed Amir Aledavood; Mona Joudi; Fatemeh Molaie; Habibollah Esmaily; Seyed Alireza Javadinia
Journal:  Cancer Rep (Hoboken)       Date:  2021-03-20

4.  Smile InTM Totems in Radiotherapy: Patients' Satisfaction with Limited Equipment and COVID-19.

Authors:  Marzia Borgia; Fiorella Cristina Di Guglielmo; Marco Lucarelli; Rosario Bonelli; Lucrezia Gasparini; Angelo Di Pilla; Lucia Anna Ursini; Maria Taraborrelli; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Marianna Trignani; Marianna Nuzzo; Consuelo Rosa; Giuditta Chiloiro; Stephanie Sartori; Lucia Ferrari; Roberta Marchione; Fabio Adalgiso D'Orazio; Paola Di Renzo; Giustino Orlando; Domenico Genovesi; Luciana Caravatta
Journal:  Healthcare (Basel)       Date:  2022-08-13

5.  COVID-19 pneumonia: Prediction of patient outcome by CT-based quantitative lung parenchyma analysis combined with laboratory parameters.

Authors:  Thuy D Do; Stephan Skornitzke; Uta Merle; Maximilian Kittel; Stefan Hofbaur; Claudius Melzig; Hans-Ulrich Kauczor; Mark O Wielpütz; Oliver Weinheimer
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

6.  COVID-19-associated disseminated mucormycosis: An autopsy case report.

Authors:  Daisuke Kyuno; Terufumi Kubo; Mitsuhiro Tsujiwaki; Shintaro Sugita; Michiko Hosaka; Hazuki Ito; Keisuke Harada; Akira Takasawa; Yusaku Kubota; Kumi Takasawa; Yusuke Ono; Kazufumi Magara; Eichi Narimatsu; Tadashi Hasegawa; Makoto Osanai
Journal:  World J Clin Cases       Date:  2022-10-06       Impact factor: 1.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.